Cornelius J. (Neil) Clancy | Associate Professor of Medicine, Infectious Diseases Division, and Director, Mycology Program
University of Pittsburgh

Cornelius J. (Neil) Clancy, Associate Professor of Medicine, Infectious Diseases Division, and Director, Mycology Program, University of Pittsburgh

Dr. Clancy is a physician and researcher with expertise in infectious diseases.  He is tenured Associate Professor of Medicine and Director of the XDR Pathogen Lab at the University of Pittsburgh.  He conducts collaborative clinical, translational and laboratory research on issues relevant to the treatment, diagnosis and prevention of infections in immunosuppressed and other vulnerable patient populations.  His research laboratory is funded by the National Institutes of Health, U.S. Department of Veterans Affairs, and industry sources.  

Dr. Clancy has published over 170 papers in medical journals, and is editor of the American Society for Microbiology’s Candida and Candidiasis textbook.  He serves on clinical and laboratory guideline committees for the Infectious Diseases Society of America, NIH Antimicrobial Resistance Leadership Group, Mycoses Study Group, European Organization for Research and Treatment of Cancer, and European Society for Clinical Microbiology.  Dr. Clancy is recognized as a Best Doctor in Pittsburgh for his clinical practice.  He has received awards for excellence in teaching medical students and residents at both the University of Pittsburgh and University of Florida.

Appearances:



World Anti-Microbial Resistance Congress USA 2018 - Day 2 @ 09:20

Keynote address: Antimicrobial Therapy for Life-Threatening Infections: Speed is Life – the devastation of a delayed diagnosis

  • We think we know, but do we? What really are the true costs of sepsis? – Mary’s Story, a 360 degree view
  • Earlier targeted antibiotic therapy with T2MR technology: It can be done
  • Utilizing same-day sepsis pathogen ID for faster therapy, enhanced stewardship, improved outcomes in practice
last published: 19/Oct/18 16:35 GMT

back to speakers